Physician profile
Arden L Aylor
NPI 1629267141
$4,808.18
in general payments reported to CMS, 2019-2025
48 companies · $504 in 2025
The $504 reported for 2025 was more than what 81% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $629 · 2021: $1,475 · 2022: $677 · 2023: $607 · 2024: $512 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.84 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $858.90 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $730.10 | 2019-2022 | |
| Abbvie INC. | $422.38 | 2021-2025 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $333.76 | 2020-2025 | Breztri, Airsupra |
| Amgen INC. | $276.54 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $260.57 | 2020-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $168.03 | 2022-2025 | |
| Lilly USA, LLC | $120.32 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Xeris Pharmaceuticals, INC. | $108.86 | 2022-2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.99 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $96.92 | 2024-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $89.09 | 2021-2022 | |
| Abbott Laboratories | $86.12 | 2021-2022 | |
| Grifols USA, LLC | $76.29 | 2021 | |
| Dexcom, INC. | $65.84 | 2021-2025 | Dexcom G6 Transmitter |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arden Aylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.